Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental
intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren
Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand
(as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment
strategy of the control intervention (on-demand) reflects current clinical practice in AS.
Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3
months after termination of the trial.